ONE YEAR ENDOSCOPIC AND HISTOLOGIC OUTCOMES TO TOFACITINIB THERAPY IN REFRACTORY ULCERATIVE COLITIS

被引：0
|
作者：
Verstockt, Bram
Alsoud, Dahham
Outtier, An
Sabino, Joao
Vermeire, Severine
De Hertogh, Gert
Ferrante, Marc
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su462
引用
收藏
页码：S702 / S702
页数：1
相关论文
共 50 条
  • [31] Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort
    Uzzan, Mathieu
    Bresteau, Clement
    Laharie, David
    Stefanescu, Carmen
    Bellanger, Christophe
    Carbonnel, Franck
    Serrero, Melanie
    Viennot, Stephanie
    Nachury, Maria
    Amiot, Aurelien
    Altwegg, Romain
    Picon, Laurence
    Nahon, Stephane
    Vuitton, Lucine
    Soune, Philippe Ah
    Kirchgesner, Julien
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (03) : 312 - 319
  • [32] Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
    Verstockt, Bram
    Volk, Valery
    Jaeckel, Charlot
    Alsoud, Dahham
    Sabino, Joao
    Nikolaus, Susanna
    Outtier, An
    Kroenke, Nicole
    Feuerhake, Friedrich
    De Hertogh, Gert
    Rosenstiel, Philip
    Vermeire, Severine
    Schreiber, Stefan
    Ferrante, Marc
    Aden, Konrad
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) : 282 - 291
  • [33] USTEKINUMAB EXPOSURE AFFECTS REAL-WORLD ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN ULCERATIVE COLITIS
    Alsoud, Dahham
    Compernolle, Griet
    Tops, Sophie
    Sabino, Joao
    Ferrante, Marc
    Thomas, Debby
    De Hertogh, Gert
    Vermeire, Severine
    Verstockt, Bram
    GASTROENTEROLOGY, 2022, 162 (07) : S819 - S819
  • [34] Real-world endoscopic and histologic outcomes are linked to ustekinumab exposure in Ulcerative Colitis
    Alsoud, D.
    Compernolle, G.
    Tops, S.
    Sabino, J.
    Ferrante, M.
    Thomas, D.
    De Hertogh, G.
    Vermeire, S.
    Verstockt, B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I424 - I424
  • [35] Discrepancies between patient-reported outcomes, endoscopic, and histologic appearance in ulcerative colitis
    Colombel, J. -F.
    Keir, M.
    Scherl, A.
    Zhao, R.
    de Hertogh, G.
    Faubion, W.
    Lu, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S61 - S61
  • [36] Discrepancies Between Patient-Reported Outcomes, Endoscopic and Histologic Appearance in Ulcerative Colitis
    Colombel, Jean-Frederic
    Keir, Mary
    Scherl, Alexis
    Zhao, Rui
    De Hertogh, Gert
    Faubion, William
    Lu, Timothy
    GASTROENTEROLOGY, 2016, 150 (04) : S992 - S992
  • [37] Real-world endoscopic and histologic outcomes are linked to ustekinumab exposure in Ulcerative Colitis
    Alsoud, D.
    Compernolle, G.
    Tops, S.
    Sabino, J.
    Ferrante, M.
    Thomas, D.
    De Hertogh, G.
    Vermeire, S.
    Verstockt, B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I424 - I424
  • [38] Quantitative endoscopic and histologic activity assessment of ulcerative colitis
    Songur, Y.
    Ensari, A.
    Savas, B.
    Senol, A.
    Percinel, S.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2009, 72 (02): : 225 - 229
  • [39] Histologic activity and clinical outcomes in Ulcerative Colitis
    Liang, R.
    Lin, H.
    Lim, W. C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 953 - 953
  • [40] Histologic healing and clinical outcomes in ulcerative colitis
    Liang, Raymond Fueng-Hin
    Lin, Huiyu
    Chau, Cora Yuk-Ping
    Lim, Wee Chian
    INTESTINAL RESEARCH, 2024,
12345